Cipla Health’s “Naselin Shubhratri Prajapati – The Guard” campaign bags “Silver” at Effie APAC Awards 2022

0
98
Cipla Health

MUMBAI: Naselin, one of the leading nasal decongestant brands by Cipla Health has swayed the stage away by winning the “Silver” at the Effie APAC Awards for its captivating yet appealing “Naselin Shubhratri, Prajapati – The Guard” campaign. Naselin becomes Cipla’s first-ever brand to win a marketing award in the Asian Pacific region, which is one of the industry’s most distinguished accolades for marketing effectiveness. APAC Effie Awards are globally recognized as the gold standard for agencies and clients alike.

Naselin has been recognized out of the 29 Indian brands and from the total of 107 brands across the Asia Pacific region which is a gratifying moment for the brand. The award-winning TVC ‘Shubhratri, Prajapati – The Guard” campaign underlines the significance of choosing the appropriate product by narrating an anecdote of a watchman who has sleep deprivation triggered by nasal congestion and struggles to get a good night’s sleep. Naselin’s decongestant nasal spray aids in relieving him from the discomfort of a blocked nose, thus ensuring a peaceful sleep.

Cipla Health Ltd understands the need of our consumers and believes in prioritizing consumer requirements and aims to provide the best-in-class offerings. Additionally, Naselin’s Nasal Decongestant spray contains Oxymetazoline Hydrochloride which aids in fast relief from the clogged nose and sinus congestion and so offers relief over a larger area.

Speaking on the win, Shivam Puri, CEO – of Cipla Health says, “I am truly pleased and humbled by this recognition being bestowed on Cipla Health. These awards are a reflection of our purposeful strides and our relentless commitment to addressing the unmet needs of our consumers. Driven by deep consumer insights and marketing expertise, Cipla Health has always strived to enhance the lives of our consumers with the most innovative and effective solutions.

LEAVE A REPLY

Please enter your comment!
Please enter your name here